ClinicalTrials.gg
DrugBiological

Aspartic Acid clinical trials

studies test it
3
open now
1
in phase 3
1
first study started
2007

How each study uses Aspartic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Aspartic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

Studies by the year they started

3 studies that test it; most in 2007 (1)

Studies that test Aspartic Acid, by start year
YearStudies
20071
20091
20261

By phase

A phase 1/2 study counts in both.

Phase 2
2
Phase 3
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 0 · Other 3

University Hospital, Caen (1) · Swiss Cancer Institute (1) · Fudan University (1)

Often tested with

Tested in the same studies.

Glutamic Acid (1) · Levulinic acid (1) · Asparaginase (1) · Etoposide (1) · Cisplatin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Aspartic Acid is the comparator. A study of two new drugs counts under both.

Studies

Open first, then newest update. How each study uses Aspartic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

As the comparator · 1 — what is tested is compared with Aspartic Acid

Codes

What other systems call Aspartic Acid · ClinicalTrials.gg INT007029

  • MeSH (NLM) D001224Aspartic AcidOne source NLM
  • UNII (FDA) 30KYC7MIAIASPARTIC ACIDConfirmed FDA, NLM, Wikidata
  • RxNorm 1169Confirmed FDA, Wikidata
  • Wikidata Q178450L-aspartic acidConfirmed FDA, NLM, Wikidata
  • Wikidata Q7226155polyaspartic acidConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29608Aspartic AcidConfirmed FDA, Wikidata
  • DrugBank DB00128One source Wikidata

Also registered as calcium aspartate (UNII T9680JD4IY · RxNorm 287637), dipotassium aspartate (UNII 74X989P9A6 · RxNorm 2397119), disodium aspartate (UNII 48MC6MXP9X · RxNorm 2619780) and magnesium aspartate (UNII R17X820ROL · RxNorm 142131).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.